301258 富士莱
已收盘 04-14 15:00:00
资讯
新帖
简况
股市必读:富士莱(301258)4月13日董秘有最新回复
证券之星 · 04-14 01:02
股市必读:富士莱(301258)4月13日董秘有最新回复
富士莱:截至2026年4月10日股东总户数为9,477户
证券之星 · 04-13 16:57
富士莱:截至2026年4月10日股东总户数为9,477户
股市必读:富士莱(301258)股东户数0.97万户,较上期增加3.1%
证券之星 · 04-07
股市必读:富士莱(301258)股东户数0.97万户,较上期增加3.1%
富士莱:截至2026年3月31日股东总户数为9,665户
证券之星 · 04-03
富士莱:截至2026年3月31日股东总户数为9,665户
富士莱(301258)披露部分董事、高级管理人员减持股份预披露公告,3月26日股价下跌1.57%
证券之星 · 03-26
富士莱(301258)披露部分董事、高级管理人员减持股份预披露公告,3月26日股价下跌1.57%
富士莱:截至2026年3月20日股东总户数为9,374户
证券之星 · 03-23
富士莱:截至2026年3月20日股东总户数为9,374户
富士莱(301258)披露2026年第一次临时股东会决议公告,3月13日股价上涨0.38%
证券之星 · 03-13
富士莱(301258)披露2026年第一次临时股东会决议公告,3月13日股价上涨0.38%
富士莱:截至2026年3月10日股东总户数为9,302户
证券之星 · 03-11
富士莱:截至2026年3月10日股东总户数为9,302户
富士莱:截至2026年2月27日股东总户数为9,426户
证券之星 · 03-03
富士莱:截至2026年2月27日股东总户数为9,426户
富士莱:截至2026年2月13日股东总户数为9,728户
证券之星 · 02-24
富士莱:截至2026年2月13日股东总户数为9,728户
富士莱:截至2026年2月10日股东总户数为9,619户
证券之星 · 02-12
富士莱:截至2026年2月10日股东总户数为9,619户
股市必读:富士莱(301258)2月5日董秘有最新回复
证券之星 · 02-06
股市必读:富士莱(301258)2月5日董秘有最新回复
富士莱:寻找协同效应并购标的适时资本运作
证券之星 · 02-05
富士莱:寻找协同效应并购标的适时资本运作
富士莱:截至2026年1月30日股东总户数为9,742户
证券之星 · 02-04
富士莱:截至2026年1月30日股东总户数为9,742户
富士莱最新公告:2025年净利同比预增282.17%-296.80%
证券之星 · 01-26
富士莱最新公告:2025年净利同比预增282.17%-296.80%
富士莱:截至目前公司不存在应披露而未披露的重大资产重组事项
证券之星 · 01-23
富士莱:截至目前公司不存在应披露而未披露的重大资产重组事项
富士莱:截至2026年1月20日股东总户数为10,050户
证券之星 · 01-21
富士莱:截至2026年1月20日股东总户数为10,050户
股市必读:富士莱(301258)1月20日董秘有最新回复
证券之星 · 01-21
股市必读:富士莱(301258)1月20日董秘有最新回复
股市必读:富士莱(301258)1月15日董秘有最新回复
证券之星 · 01-16
股市必读:富士莱(301258)1月15日董秘有最新回复
富士莱:目前暂无AI在制药领域的业务布局
证券之星 · 01-15
富士莱:目前暂无AI在制药领域的业务布局
加载更多
公司概况
公司名称:
苏州富士莱医药股份有限公司
所属行业:
医药制造业
上市日期:
2022-03-29
主营业务:
苏州富士莱医药股份有限公司的主营业务是医药中间体、原料药及保健品原料的研发、生产和销售。公司的主要产品是硫辛酸系列、磷脂酰胆碱系列、肌肽系列、艾瑞昔布。公司多年来连续被认定为“高新技术企业”。
发行价格:
48.30
{"stockData":{"symbol":"301258","market":"SZ","secType":"STK","nameCN":"富士莱","latestPrice":32.1,"timestamp":1776150207000,"preClose":32,"halted":0,"volume":783300,"delay":0,"changeRate":0.0031,"floatShares":89065000,"shares":91670000,"eps":0.8287,"marketStatus":"已收盘","change":0.1,"latestTime":"04-14 15:00:00","open":32.21,"high":32.21,"low":31.7,"amount":25025100,"amplitude":0.0159,"askPrice":32.1,"askSize":155,"bidPrice":32.08,"bidSize":7,"shortable":0,"etf":0,"ttmEps":0.8287,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776216600000},"marketStatusCode":5,"adr":0,"adjPreClose":32,"symbolType":"stock","openAndCloseTimeList":[[1776130200000,1776137400000],[1776142800000,1776150000000]],"highLimit":35.2,"lowLimit":28.8,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":91670000,"isCdr":false,"pbRate":1.53,"roa":"--","peRate":38.735369,"roe":"3.83%","epsLYR":0.18,"committee":-0.619048,"marketValue":2943000000,"turnoverRate":0.0088,"status":0,"floatMarketCap":2859000000},"requestUrl":"/m/hq/s/301258","defaultTab":"news","newsList":[{"id":"2627457495","title":"股市必读:富士莱(301258)4月13日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2627457495","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627457495?lang=zh_cn&edition=full","pubTime":"2026-04-14 01:02","pubTimestamp":1776099734,"startTime":"0","endTime":"0","summary":"截至2026年4月13日收盘,富士莱报收于32.0元,下跌0.99%,换手率1.23%,成交量1.1万手,成交额3509.01万元。截至2026年4月10日股东总户数为9,477户,感谢您对公司的关注!投资者: 您好董秘,请问2026年4月10日公司股东人数有多少?当日关注点来自交易信息汇总:4月13日主力资金净流出12.87万元,游资资金净流入355.23万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041400000781.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301258"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627435925","title":"富士莱:截至2026年4月10日股东总户数为9,477户","url":"https://stock-news.laohu8.com/highlight/detail?id=2627435925","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627435925?lang=zh_cn&edition=full","pubTime":"2026-04-13 16:57","pubTimestamp":1776070649,"startTime":"0","endTime":"0","summary":"证券之星消息,富士莱(301258)04月13日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司截止4月10日的股东人数是多少?谢谢。富士莱回复:尊敬的投资者,您好!截至2026年4月10日股东总户数为9,477户,感谢您对公司的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041300021406.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301258"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625601991","title":"股市必读:富士莱(301258)股东户数0.97万户,较上期增加3.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625601991","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625601991?lang=zh_cn&edition=full","pubTime":"2026-04-07 04:28","pubTimestamp":1775507293,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘,富士莱报收于30.99元,下跌4.17%,换手率1.03%,成交量9135.0手,成交额2870.69万元。交易信息汇总资金流向4月3日主力资金净流出139.84万元,占总成交额4.87%;游资资金净流入174.28万元,占总成交额6.07%;散户资金净流出34.45万元,占总成交额1.2%。股本股东变化股东户数变动近日富士莱披露,截至2026年3月31日公司股东户数为9665.0户,较3月20日增加291.0户,增幅为3.1%。户均持股数量由上期的9779.0股减少至9485.0股,户均持股市值为30.11万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700002611.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301258","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624365856","title":"富士莱:截至2026年3月31日股东总户数为9,665户","url":"https://stock-news.laohu8.com/highlight/detail?id=2624365856","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624365856?lang=zh_cn&edition=full","pubTime":"2026-04-03 08:45","pubTimestamp":1775177111,"startTime":"0","endTime":"0","summary":"证券之星消息,富士莱(301258)04月02日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好,请问截至2026年3月31日,公司股东人数有多少?富士莱回复:尊敬的投资者,您好!截至2026年3月31日股东总户数为9,665户,感谢您对公司的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300009126.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301258"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622534168","title":"富士莱(301258)披露部分董事、高级管理人员减持股份预披露公告,3月26日股价下跌1.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622534168","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622534168?lang=zh_cn&edition=full","pubTime":"2026-03-26 17:35","pubTimestamp":1774517754,"startTime":"0","endTime":"0","summary":"截至2026年3月26日收盘,富士莱报收于30.67元,较前一交易日下跌1.57%,最新总市值为28.12亿元。该股当日开盘31.0元,最高31.77元,最低30.53元,成交额达2839.03万元,换手率为1.03%。近日,苏州富士莱医药股份有限公司发布《关于部分董事、高级管理人员减持股份预披露公告》。公告显示,公司董事、高级管理人员卞爱进先生持有公司股份200,000股,计划减持50,000股;董事陆建刚先生持有公司股份350,000股,计划减持87,500股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032600032050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301258","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621077694","title":"富士莱:截至2026年3月20日股东总户数为9,374户","url":"https://stock-news.laohu8.com/highlight/detail?id=2621077694","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621077694?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:48","pubTimestamp":1774255689,"startTime":"0","endTime":"0","summary":"证券之星消息,富士莱(301258)03月23日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘,您好!敬请发布截至3月20日公司的股东户数信息,谢谢!富士莱回复:尊敬的投资者,您好!截至2026年3月20日股东总户数为9,374户,感谢您对公司的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300025596.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301258","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619152771","title":"富士莱(301258)披露2026年第一次临时股东会决议公告,3月13日股价上涨0.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619152771","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619152771?lang=zh_cn&edition=full","pubTime":"2026-03-13 22:47","pubTimestamp":1773413233,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘,富士莱报收于34.47元,较前一交易日上涨0.38%,最新总市值为31.6亿元。该股当日开盘34.17元,最高34.91元,最低34.07元,成交额达3004.11万元,换手率为0.98%。公司于近日披露《2026年第一次临时股东会决议公告》。公告显示,苏州富士莱医药股份有限公司于2026年3月13日召开2026年第一次临时股东会,会议采用现场与网络投票相结合方式召开,出席会议股东共64人,代表股份56,156,960股,占公司有表决权股份总数的63.3897%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300041968.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301258"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618912806","title":"富士莱:截至2026年3月10日股东总户数为9,302户","url":"https://stock-news.laohu8.com/highlight/detail?id=2618912806","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618912806?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:27","pubTimestamp":1773217628,"startTime":"0","endTime":"0","summary":"证券之星消息,富士莱(301258)03月11日在投资者关系平台上答复投资者关心的问题。投资者提问:您好,请问截止2026年3月10日,公司股东数是多少?富士莱回复:尊敬的投资者,您好!截至2026年3月10日股东总户数为9,302户,感谢您对公司的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100026760.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301258","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616314789","title":"富士莱:截至2026年2月27日股东总户数为9,426户","url":"https://stock-news.laohu8.com/highlight/detail?id=2616314789","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616314789?lang=zh_cn&edition=full","pubTime":"2026-03-03 16:12","pubTimestamp":1772525529,"startTime":"0","endTime":"0","summary":"证券之星消息,富士莱(301258)03月03日在投资者关系平台上答复投资者关心的问题。投资者提问:您好,请问截至2026年2月底,公司股东人数有多少?富士莱回复:尊敬的投资者,您好!截至2026年2月27日股东总户数为9,426户,感谢您对公司的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300027854.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301258","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613793343","title":"富士莱:截至2026年2月13日股东总户数为9,728户","url":"https://stock-news.laohu8.com/highlight/detail?id=2613793343","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613793343?lang=zh_cn&edition=full","pubTime":"2026-02-24 15:57","pubTimestamp":1771919837,"startTime":"0","endTime":"0","summary":"证券之星消息,富士莱(301258)02月24日在投资者关系平台上答复投资者关心的问题。投资者提问:请问最新一期公司的股东人数是多少?谢谢富士莱回复:尊敬的投资者,您好!截至2026年2月13日股东总户数为9,728户,感谢您对公司的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400026957.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301258"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610994477","title":"富士莱:截至2026年2月10日股东总户数为9,619户","url":"https://stock-news.laohu8.com/highlight/detail?id=2610994477","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610994477?lang=zh_cn&edition=full","pubTime":"2026-02-12 11:33","pubTimestamp":1770867213,"startTime":"0","endTime":"0","summary":"证券之星消息,富士莱(301258)02月11日在投资者关系平台上答复投资者关心的问题。投资者提问:您好,请问截至2026年2月10日,公司股东人数有多少?富士莱回复:尊敬的投资者,您好!截至2026年2月10日股东总户数为9,619户,感谢您对公司的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021200014327.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301258"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609458563","title":"股市必读:富士莱(301258)2月5日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2609458563","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609458563?lang=zh_cn&edition=full","pubTime":"2026-02-06 02:34","pubTimestamp":1770316451,"startTime":"0","endTime":"0","summary":"截至2026年2月5日收盘,富士莱报收于34.18元,上涨0.41%,换手率1.41%,成交量1.26万手,成交额4315.37万元。董秘最新回复投资者: 钱总,您好,公司上市这么多年长期破发,请抓紧学习并购重组六条,早日让公司多元化发展,这样才能对得起长期坚守的小股东?当日关注点来自交易信息汇总:2月5日主力资金净流入104.19万元,游资积极介入,散户资金呈净流出态势。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020600001925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301258","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609706613","title":"富士莱:寻找协同效应并购标的适时资本运作","url":"https://stock-news.laohu8.com/highlight/detail?id=2609706613","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609706613?lang=zh_cn&edition=full","pubTime":"2026-02-05 20:48","pubTimestamp":1770295719,"startTime":"0","endTime":"0","summary":"证券之星消息,富士莱02月05日在投资者关系平台上答复投资者关心的问题。公司在深耕主营业务、加强研发投入,谋求内生式发展的同时,也在寻找能够与公司产生协同效应的并购标的,适时通过资本运作扩展产业布局,通过收购兼并、参股控股等方式,寻求外延并购等发展机会,实现产业资源整合,促进公司稳健发展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500037515.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301258"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608595355","title":"富士莱:截至2026年1月30日股东总户数为9,742户","url":"https://stock-news.laohu8.com/highlight/detail?id=2608595355","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608595355?lang=zh_cn&edition=full","pubTime":"2026-02-04 15:48","pubTimestamp":1770191290,"startTime":"0","endTime":"0","summary":"证券之星消息,富士莱(301258)02月04日在投资者关系平台上答复投资者关心的问题。投资者提问:请问2026年1月底公司股东人数是多少?富士莱回复:尊敬的投资者,您好!截至2026年1月30日股东总户数为9,742户,感谢您对公司的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400022556.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301258","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606248330","title":"富士莱最新公告:2025年净利同比预增282.17%-296.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606248330","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606248330?lang=zh_cn&edition=full","pubTime":"2026-01-26 20:50","pubTimestamp":1769431817,"startTime":"0","endTime":"0","summary":"富士莱(301258.SZ)发布2025年度业绩预告,预计归属于上市公司股东的净利润为0.63亿元–0.65亿元,比上年同期增长282.17%–296.80%。业绩变动原因:主要产品出货量稳定增长,叠加非经常性损益约0.68亿元(主要为理财产品投资收益及公允价值变动损益)。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600033006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301258","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605422172","title":"富士莱:截至目前公司不存在应披露而未披露的重大资产重组事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2605422172","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605422172?lang=zh_cn&edition=full","pubTime":"2026-01-23 15:48","pubTimestamp":1769154484,"startTime":"0","endTime":"0","summary":"证券之星消息,富士莱(301258)01月22日在投资者关系平台上答复投资者关心的问题。投资者提问:请董秘介绍一下公司在并购重组方面的未来规划?公司如何把握行业整合机遇,提升核心竞争力?富士莱回复:尊敬的投资者,您好!截至目前,公司不存在应披露而未披露的重大资产重组事项。未来,如有符合公司发展战略、有利于提升公司核心竞争力和盈利能力的并购或合作机会,公司将会在充分考虑风险因素和投资回报的基础上,进行审慎评估和决策,谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300020142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301258"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605617235","title":"富士莱:截至2026年1月20日股东总户数为10,050户","url":"https://stock-news.laohu8.com/highlight/detail?id=2605617235","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605617235?lang=zh_cn&edition=full","pubTime":"2026-01-21 16:51","pubTimestamp":1768985474,"startTime":"0","endTime":"0","summary":"证券之星消息,富士莱(301258)01月21日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截至2026年1月20日,公司股东人数有多少?富士莱回复:尊敬的投资者,您好!截至2026年1月20日股东总户数为10,050户,感谢您对公司的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100027256.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301258","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605452351","title":"股市必读:富士莱(301258)1月20日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2605452351","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605452351?lang=zh_cn&edition=full","pubTime":"2026-01-21 03:25","pubTimestamp":1768937111,"startTime":"0","endTime":"0","summary":"截至2026年1月20日收盘,富士莱报收于37.28元,上涨1.0%,换手率4.25%,成交量3.79万手,成交额1.42亿元。董秘最新回复投资者: 尊敬的董秘您好,关注到公司此前曾布局小核酸业务,但之前公开信息显示相关设备已出售、项目终止。前期购置的部分寡核苷酸中试设备因不再适应当前业务需求,公司已于2024年度对相关设备进行处置。交易信息汇总资金流向1月20日主力资金净流出122.95万元;游资资金净流出1010.33万元;散户资金净流入1133.28万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100002683.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301258"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603151980","title":"股市必读:富士莱(301258)1月15日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2603151980","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603151980?lang=zh_cn&edition=full","pubTime":"2026-01-16 02:38","pubTimestamp":1768502290,"startTime":"0","endTime":"0","summary":"截至2026年1月15日收盘,富士莱报收于35.03元,上涨2.49%,换手率2.19%,成交量1.95万手,成交额6805.14万元。投资者: 以“AI+发酵+合成生物学”的落地应用,践行AI4S核心逻辑,属于AI4S在生物医药制造领域的典型产业应用案例公司有这方便的运用吗?公司密切关注AI在制药领域的应用和发展,目前暂无相关业务布局。当日关注点来自交易信息汇总:1月15日主力资金净流入825.41万元,呈现明显吸筹迹象。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011600001080.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301258","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603607259","title":"富士莱:目前暂无AI在制药领域的业务布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2603607259","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603607259?lang=zh_cn&edition=full","pubTime":"2026-01-15 20:48","pubTimestamp":1768481302,"startTime":"0","endTime":"0","summary":"证券之星消息,富士莱(301258)01月15日在投资者关系平台上答复投资者关心的问题。投资者提问:以“AI+发酵+合成生物学”的落地应用,践行AI4S核心逻辑(数据与模型驱动科研生产,提升效率、缩短周期),属于AI4S在生物医药制造领域的典型产业应用案例公司有这方便的运用吗?富士莱回复:尊敬的投资者,您好!公司密切关注AI在制药领域的应用和发展,目前暂无相关业务布局。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500038639.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301258","BK0239","BK1574","01477","BK1191"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1776183907372,"stockEarnings":[{"period":"1week","weight":-0.0037},{"period":"1month","weight":-0.0688},{"period":"3month","weight":-0.0609},{"period":"6month","weight":-0.0652},{"period":"1year","weight":0.3259},{"period":"ytd","weight":-0.0123}],"compareEarnings":[{"period":"1week","weight":0.0351},{"period":"1month","weight":-0.0168},{"period":"3month","weight":-0.0241},{"period":"6month","weight":0.0282},{"period":"1year","weight":0.2341},{"period":"ytd","weight":0.0146}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"苏州富士莱医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"9477人(较上一季度减少1.95%)","perCapita":"9398股","listingDate":"2022-03-29","address":"江苏省苏州市常熟市新材料产业园海旺路16号","registeredCapital":"9167万元","survey":" 苏州富士莱医药股份有限公司的主营业务是医药中间体、原料药及保健品原料的研发、生产和销售。公司的主要产品是硫辛酸系列、磷脂酰胆碱系列、肌肽系列、艾瑞昔布。公司多年来连续被认定为“高新技术企业”。","listedPrice":48.3},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"富士莱(301258)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供富士莱(301258)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"富士莱,301258,富士莱股票,富士莱股票老虎,富士莱股票老虎国际,富士莱行情,富士莱股票行情,富士莱股价,富士莱股市,富士莱股票价格,富士莱股票交易,富士莱股票购买,富士莱股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"富士莱(301258)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供富士莱(301258)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}